Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease.

Li D, Liu MS, Ji B, Hwang KC, Huang Y.

Chem Biol Drug Des. 2012 Sep;80(3):440-54. doi: 10.1111/j.1747-0285.2012.01417.x. Epub 2012 Jun 27.

PMID:
22621379
2.

Insight into the folding inhibition of the HIV-1 protease by a small peptide.

Bonomi M, Gervasio FL, Tiana G, Provasi D, Broglia RA, Parrinello M.

Biophys J. 2007 Oct 15;93(8):2813-21. Epub 2007 Jun 15.

3.

Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.

Lee VS, Nimmanpipug P, Aruksakunwong O, Promsri S, Sompornpisut P, Hannongbua S.

J Mol Graph Model. 2007 Sep;26(2):558-70. Epub 2007 Apr 4.

PMID:
17468026
4.

Automated docking of highly flexible ligands by genetic algorithms: a critical assessment.

Cecchini M, Kolb P, Majeux N, Caflisch A.

J Comput Chem. 2004 Feb;25(3):412-22.

PMID:
14696075
5.

Advances in automated docking applied to human immunodeficiency virus type 1 protease.

Miller MD, Sheridan RP, Kearsley SK, Underwood DJ.

Methods Enzymol. 1994;241:354-70. No abstract available.

PMID:
7854188

Supplemental Content

Loading ...
Support Center